Ms. Tranowski has over 20 years experience building and leading global drug development teams.  She was instrumental in the approvals of Trodelvy®, triple negative breast cancer, Xtandi® prostate cancer, FluMist®, nasal flu vaccine and Increlex®, recombinant human insulin-like growth factor. Additional accomplishments include partnering with CEOs to develop strategic plans and optimize portfolios. Ms. Tranowski received her BS in Computer Science and Mathematics at the University of Maryland and has an Advanced Project Management certification from Stanford University.